Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The objective of the study is to evaluate the efficacy and safety of chemotherapy plus deferoxamine in metastatic breast cancer whose evaluation is stable disease with a trend of progression.
Epistemonikos ID: 15cd6630b28ae23db49138cc9ccd4218c191b9cc
First added on: May 10, 2024